CT Healthcare Trust PLC

CT Healthcare Trust PLC exhibits a highly leveraged price-to-book ratio of 53.98, significantly above the median for UK Investment Trusts, indicating a premium valuation relative to its book value. The company's liquidity position is characterized by a current ratio of 4.99, suggesting strong short-term liquidity, although its operating cash flow of -1.27 million GBP indicates ongoing cash outflows from operations. Profitability metrics are negative, with a return on equity of -38.65% and a return on assets of -38.29%, both well below the industry median for UK Investment Trusts. The company's net income of -52.13 million GBP and operating income of -51.61 million GBP reflect a challenging operating environment. Geographically, the company's revenue is not disclosed by segment or region, but as a UK-based investment trust, its exposure is likely diversified across global healthcare markets. The company's total assets of 136.15 million GBP are primarily equity-based, with no long-term debt. The company's growth trajectory is uncertain, with no revenue growth reported in the latest period. The absence of long-term debt and a low dilution risk suggest a stable capital structure, but the negative net income and operating cash flow raise concerns about long-term sustainability. Risk factors include low liquidity and the potential for continued negative returns. The company has no immediate filing-based liquidity or dilution flags, but its negative operating cash flow and high price-to-book ratio suggest potential liquidity constraints in the future. Recent events include the company's continued focus on the global healthcare market, with no significant new filings or transcripts indicating strategic shifts. The company's ESG controversies score of 100.0 suggests no major controversies, but its governance and social pillar scores are below the industry median.